ImpriMed
Jinjoo Kim is a Korean national who is currently the Director at ImpriMed. Jinjoo has extensive experience in the medical field, having worked as a Gastroenterology Assistant Professor at Gyeongsang National University hospital from 2015 to 2018, and as a Clinical Assistant Professor at Seoul National University Hospital from 2006 to 2015. Her previous company was Daylipartners, where they worked as a Director from January 2019 to June 2020.
Jinjoo Kim earned their PhD in Internal Medicine from Seoul National University. Jinjoo also has a Master's degree in internal medicine from the same school. Prior to their PhD, they completed their Doctor of Medicine (MD) degree in medicine from Seoul National University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ImpriMed
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.